Get the Stockscreener App
1.70
8.60%
-0.16
After Hours:
1.73
0.03
+1.76%
Serina Therapeutics Inc stock is traded at $1.70, with a volume of 164.77K.
It is down -8.60% in the last 24 hours and down -31.17% over the past month.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.
See More
Previous Close:
$1.86
Open:
$1.84
24h Volume:
164.77K
Relative Volume:
0.14
Market Cap:
$18.34M
Revenue:
$144.00K
Net Income/Loss:
$-14.50M
P/E Ratio:
-1.1723
EPS:
-1.4501
Net Cash Flow:
$-14.95M
1W Performance:
-31.17%
1M Performance:
-31.17%
6M Performance:
-68.86%
1Y Performance:
-63.04%
1-Day Range:
$1.6506
$1.84
1-Week Range:
$1.6506
$2.47
52-Week Range:
$1.6506
$7.92
Serina Therapeutics Inc Stock (SER) Company Profile
Name
Serina Therapeutics Inc
Sector
Industry
Phone
(256) 327-9630
Address
601 GENOME WAY, HUNTSVILLE
Compare SER vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SER
Serina Therapeutics Inc
|
1.70 | 20.06M | 144.00K | -14.50M | -14.95M | -1.4501 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-14-25 | Initiated | H.C. Wainwright | Buy |
Serina Therapeutics Inc Stock (SER) Latest News
Aug EndMonth: Is Serina Therapeutics Inc being accumulated by smart moneyTrade Exit Report & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Aug Drivers: Whats next for Marchex Inc stockShort Setup & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Serina Therapeutics CSO sells $19,680 in shares By Investing.com - Investing.com South Africa
Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event - The Globe and Mail
Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event - Finviz
Bull Bear: Is Serina Therapeutics Inc a stock for growth or value investorsTrade Entry Summary & Smart Swing Trading Techniques - baoquankhu1.vn
Stock Recap: Is Serina Therapeutics Inc a stock for growth or value investorsEarnings Performance Report & High Conviction Investment Ideas - baoquankhu1.vn
Why did SER stock surge over 70% in pre-market today? - MSN
Bull Run: What are Serina Therapeutics Incs recent SEC filings showingMarket Growth Report & Weekly Setup with High ROI Potential - baoquankhu1.vn
Serina Therapeutics CSO sells $23,185 in shares By Investing.com - Investing.com Canada
Serina Therapeutics CSO sells $23,185 in shares - Investing.com
Serina Therapeutics Stock Soars Amid Strategic Partnership Announcements - StocksToTrade
Serina Therapeutics Announces FDA Clearance of IND - GlobeNewswire
Serina Jumps On FDA's IND Clearance For SER-252 In Advanced Parkinson's Disease After Clinical Hold - Nasdaq
What Sparked Serina Therapeutics (SER) 35% After-Hours Surge? - Finviz
Serina Therapeutics stock soars after FDA clears IND for Parkinson’s drug By Investing.com - Investing.com South Africa
Serina Therapeutics stock soars after FDA clears IND for Parkinson’s drug - Investing.com UK
Serina Therapeutics announces FDA clearance of IND application for SER-252 for the treatment of advanced Parkinson's disease - marketscreener.com
Serina Therapeutics Announces FDA Clearance of IND Application for SER-252 for the Treatment of Advanced Parkinson’s disease - The Manila Times
Serina Therapeutics, Inc. Announces FDA Clearance for SER-252 IND - TradingView
FDA clears trial of new advanced Parkinson’s therapy SER-252 - stocktitan.net
New Highs: Why is Serina Therapeutics Inc stock going upJuly 2025 Update & Weekly Breakout Stock Alerts - baoquankhu1.vn
Serina Therapeutics CSO sells $7375 in shares By Investing.com - Investing.com Canada
Aug Technicals: Is Serina Therapeutics Inc benefiting from innovation trends2025 Biggest Moves & Daily Growth Stock Investment Tips - baoquankhu1.vn
Serina Therapeutics CSO sells $12,140 in shares By Investing.com - Investing.com UK
Serina Therapeutics CSO sells $12,140 in shares - Investing.com
Geopolitics Watch: Why is Serina Therapeutics Inc stock going upTrade Risk Summary & Accurate Trade Setup Notifications - baoquankhu1.vn
Winners Losers: What is the dividend yield of Serina Therapeutics IncJuly 2025 Action & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Serina Therapeutics receives NYSE notification - MSN
Serina Therapeutics (SER) Receives NYSE Deficiency Notice for Low Stockholders' Equity - Intellectia AI
Serina Therapeutics Faces NYSE American Compliance Deficiency Notice - The Globe and Mail
Serina Therapeutics Receives NYSE Deficiency Notice; Stock Edges Down - Nasdaq
Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' Equity - The Globe and Mail
Serina Therapeutics receives NYSE listing deficiency notice - Investing.com
Serina Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Serina Therapeutics receives NYSE listing deficiency notice By Investing.com - Investing.com Nigeria
Serina Therapeutics CSO Moreadith sells shares for $16,253 - Investing.com
Serina Therapeutics CSO Moreadith sells shares for $16,253 By Investing.com - Investing.com Australia
What is the fair value of Serina Therapeutics Inc. stock nowJuly 2025 Selloffs & Weekly Market Pulse Updates - ulpravda.ru
Serina Therapeutics CSO Moreadith sells $34,953 in shares By Investing.com - Investing.com Canada
Serina Therapeutics (SER) Chief Scientific Officer reports 13,000-share sale - Stock Titan
Will Serina Therapeutics Inc. (2BO) stock split increase liquidityWide Width Options & walk-ready comfort choices - ulpravda.ru
Serina Therapeutics, Inc. Common Stock (NYSE:SER) Stock Quote - FinancialContent
Buybacks Report: How supply chain issues affect Serina Therapeutics Inc. stockQuarterly Profit Review & Technical Pattern Based Buy Signals - Улправда
Will Serina Therapeutics Inc. stock continue dividend increasesPortfolio Risk Report & Long Hold Capital Preservation Tips - Улправда
Why Serina Therapeutics Inc. stock attracts global investorsWeekly Trade Review & AI Forecast for Swing Trade Picks - ulpravda.ru
Serina Therapeutics Inc Stock (SER) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Cap:
|
Volume (24h):